MX2022005362A - Composiciones de trem para codones con-raros y usos relacionados. - Google Patents

Composiciones de trem para codones con-raros y usos relacionados.

Info

Publication number
MX2022005362A
MX2022005362A MX2022005362A MX2022005362A MX2022005362A MX 2022005362 A MX2022005362 A MX 2022005362A MX 2022005362 A MX2022005362 A MX 2022005362A MX 2022005362 A MX2022005362 A MX 2022005362A MX 2022005362 A MX2022005362 A MX 2022005362A
Authority
MX
Mexico
Prior art keywords
con
trem
compositions
rare codons
related uses
Prior art date
Application number
MX2022005362A
Other languages
English (en)
Inventor
David Arthur Berry
Theonie Anastassiadis
Christine Elizabeth Hajdin
Noubar Boghos Afeyan
Original Assignee
Flagship Pioneering Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Inc filed Critical Flagship Pioneering Inc
Publication of MX2022005362A publication Critical patent/MX2022005362A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)

Abstract

En general, la invención se refiere a usos de moléculas efectoras basadas en ARNt (TREM) correspondientes a codones con-raros y métodos de preparación de las mismas.
MX2022005362A 2019-11-04 2020-11-04 Composiciones de trem para codones con-raros y usos relacionados. MX2022005362A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962930361P 2019-11-04 2019-11-04
PCT/US2020/058948 WO2021092064A1 (en) 2019-11-04 2020-11-04 Trem compositions for con-rare codons and related uses

Publications (1)

Publication Number Publication Date
MX2022005362A true MX2022005362A (es) 2022-09-23

Family

ID=73654885

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022005362A MX2022005362A (es) 2019-11-04 2020-11-04 Composiciones de trem para codones con-raros y usos relacionados.

Country Status (9)

Country Link
US (1) US20220364092A1 (es)
EP (1) EP4055163A1 (es)
JP (1) JP2023500116A (es)
KR (1) KR20220128611A (es)
CN (1) CN115003810A (es)
AU (1) AU2020379762A1 (es)
CA (1) CA3160097A1 (es)
MX (1) MX2022005362A (es)
WO (1) WO2021092064A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3081692A1 (en) 2017-11-02 2019-05-09 The Wistar Institute Of Anatomy And Biology Methods of rescuing stop codons via genetic reassignment with ace-trna
CA3182026A1 (en) * 2020-05-29 2021-12-02 Flagship Pioneering Innovations Vi, Llc. Trem compositions and methods relating thereto
MX2022015042A (es) * 2020-05-29 2023-03-09 Flagship Pioneering Innovations Vi Llc Composiciones de trem y métodos relacionados con las mismas.

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801030A (en) 1995-09-01 1998-09-01 Genvec, Inc. Methods and vectors for site-specific recombination
US6693086B1 (en) 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
GB2442881B (en) * 2005-03-25 2010-08-04 Uab Research Foundation Methods for altering gene expression and methods of treatment utilizing same
GB0600948D0 (en) * 2006-01-18 2006-02-22 Univ Dundee Prevention/Treatment Of Ichthyosis Vulgaris, Atopy And Other Disorders
WO2010141851A1 (en) * 2009-06-05 2010-12-09 Salk Institute For Biological Studies Improving unnatural amino acid incorporation in eukaryotic cells
US9676810B2 (en) * 2010-07-08 2017-06-13 The Brigham And Women's Hospital, Inc. Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules
US9267108B2 (en) * 2012-10-02 2016-02-23 Vaxiion Therapeutics, Llc Immunomodulatory minicells and methods of use
WO2015073587A2 (en) 2013-11-18 2015-05-21 Rubius Therapeutics, Inc. Synthetic membrane-receiver complexes
ES2865825T3 (es) 2014-04-01 2021-10-18 Rubius Therapeutics Inc Procedimientos y composiciones para inmunomodulación
US20180135012A1 (en) 2015-05-13 2018-05-17 Rubius Therapeutics, Inc. Membrane-receiver complex therapeutics
HRP20220147T1 (hr) 2016-01-11 2022-04-15 Rubius Therapeutics, Inc. Pripravci i postupci povezani s multimodalnim terapijskim staničnim sustavima za indikacije raka
AU2017293931A1 (en) 2016-07-07 2019-01-17 Rubius Therapeutics, Inc. Compositions and methods related to therapeutic cell systems expressing exogenous RNA
JP2019536793A (ja) 2016-12-02 2019-12-19 ルビウス セラピューティクス， インコーポレイテッド 固形腫瘍に浸透させるための細胞系に関連する組成物および方法
AU2018221227A1 (en) 2017-02-17 2019-08-15 Rubius Therapeutics, Inc. Functionalized erythroid cells
IL270496B1 (en) 2017-05-08 2024-07-01 Flagship Pioneering Innovations V Inc Intra-membrane aid preparations and their uses
WO2020069199A1 (en) * 2018-09-26 2020-04-02 Case Western Reserve University Methods and compositions for increasing protein expression and/or treating a haploinsufficiency disorder
BR112021013934A2 (pt) * 2019-01-18 2021-09-21 Flagship Pioneering, Inc. Composições de trem e seus usos
US20220228147A1 (en) * 2019-05-31 2022-07-21 Flagship Pioneering, Inc. Uses of trem compositions to modulate trna pools

Also Published As

Publication number Publication date
AU2020379762A1 (en) 2022-05-26
WO2021092064A1 (en) 2021-05-14
CN115003810A (zh) 2022-09-02
JP2023500116A (ja) 2023-01-04
CA3160097A1 (en) 2021-05-14
KR20220128611A (ko) 2022-09-21
US20220364092A1 (en) 2022-11-17
EP4055163A1 (en) 2022-09-14

Similar Documents

Publication Publication Date Title
MX2021008592A (es) Composiciones de trem y usos de las mismas.
MX2021014441A (es) Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos.
PH12019501812A1 (en) Compositions and methods for the treatment of hemoglobinopathies
WO2020039321A3 (en) Anti-gdf15 antibodies, compositions and methods of use
MX2022005362A (es) Composiciones de trem para codones con-raros y usos relacionados.
CA3010752A1 (en) Inhibitors of the pd-1/pd-l1 protein/protein interaction
MX2021012216A (es) Degradadores de transductores de señal y activadores de transcripción (stat) y usos de los mismos.
EP4112611A3 (en) Modulators of sestrin-gator2 interaction and uses thereof
PH12020500105A1 (en) Bicyclic ketone compounds and methods of use thereof
MX2022012955A (es) Composiciones de trem y usos de las mismas.
WO2018217894A8 (en) FLUORINATED MARKED HALICHONDRIN DERIVATIVES AND METHODS OF SYNTHESIS THEREOF
MX2019013419A (es) Compuestos plaguicidas biciclicos.
ZA202309446B (en) Rapamycin analogs and uses thereof
WO2020123816A3 (en) Anellosomes and methods of use
MX2022007841A (es) Degradadores del regulador dependiente de actina asociado a la matriz relacionado con el complejo switch/sacarosa no fermentable de la subfamilia a de la cromatina (smarca)y usos de los mismos.
GB2568181A (en) Wheat
EP3795578A3 (en) Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof
MX2021006515A (es) Composiciones de methylobacterium para mejorar el rendimiento del maíz.
MX2021003180A (es) Métodos y kits para preparar sangre entera con inactivación de patógenos.
MX2022001449A (es) Compuestos de aminoesterol humano ent-03, composiciones relacionadas que comprenden los mismos y metodos para usar los mismos.
PH12019502694A1 (en) Anti-trkb antibodies
MX2022001641A (es) Composiciones fermentadas y procedimientos de preparacion de las mismas.
MX2021011976A (es) Composiciones de control de artropodos.
MX2019004182A (es) Proceso para la fabricacion de 2,6-dimetil-5-hepten-1-al.
WO2019224548A3 (en) Methods for the production of methacrylates